Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors

Abstract

The aim of this study was to evaluate the biological profile of odontogenic epithelium by immunolabeling of epidermal growth factor receptor (EGFR), Ki-67 and survivin in keratocystic odontogenic tumors (KOT), dentigerous cysts (DC), and pericoronal follicles (PF). Immunohistochemical analysis was performed in 13 KOTs, 14 DCs and 9 PFs. Immunolabeling was analyzed in the basal and suprabasal layers of KOTs and DCs, and in the islands of odontogenic epithelium and/or reduced enamel epithelium of PFs. KOTs showed the highest proliferation rate among the three groups, mainly in suprabasal layers. EGFR immunolabeling was observed mainly in the cytoplasm in basal and suprabasal layers of KOTs and in the suprabasal layer of DCs. Immunolabeling in both membrane and cytoplasm was greater in PFs. In PFs, membrane-only staining was observed. Survivin immunolabeling showed a greater percentage of positive cells (scoring +++) in the suprabasal layer of KOTs. In DCs, both layers showed similar percentages of cells scoring +++; PFs showed the highest percentage of these cells. In KOTs, epithelial cells showed stimulus-independent neoplastic proliferative characteristics, suggesting the presence of a suprabasal proliferative compartment, maintained by inhibition of apoptosis. In DCs, the basal layer seemed to proliferate in response to stimulus. Although PFs showed low proliferative activity, the expression of EGFR indicates that some cells have a high capacity to respond to stimuli, which could probably explain the origin of odontogenic lesions.

Fig. 1

Keratocystic odontogenic tumor: Ki-67 immunolabeling predominantly in the suprabasal layer (a); epidermal growth factor receptor (EGFR) immunolabeling mainly in the cytoplasm (b); survivin immunolabeling predominantly scoring as +++ in the suprabasal layer (c) (400× magnification)

Fig. 2

Dentigerous cyst: Ki-67 immunolabeling in the basal layer (a); epidermal growth factor receptor (EGFR) immunolocation predominantly in cytoplasm in the suprabasal layers (b); survivin immunolabeling predominantly scoring as +++ in both layers (c) (400× magnification)

Fig. 3

Pericoronal follicles: Ki-67 immunolabeling in some epithelial cells (a); EGFR immunolabeling in the membrane of reduced enamel epithelium (b); survivin immunolabeling predominantly scoring as +++ (c) (400× magnification)